Patent ID: 11872309
Assignee: nan
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  Y | IPC A

Claim 21:
22. The method of claim 1, wherein the oral liquid suspension is administered, such that
2.5±0.25 mg topiramate in 0.1 mL of the oral liquid suspension, or
5±0.5 mg topiramate in 0.2 mL of the oral liquid suspension, or
10±1.0 mg topiramate in 0.4 mL of the oral liquid suspension, or
12.5±1.25 mg topiramate in 0.5 mL of the oral liquid suspension, or
15±1.5 mg topiramate in 0.6 mL of the oral liquid suspension, or
20±2.0 mg topiramate in 0.8 mL of the oral liquid suspension, or
25±2.5 mg topiramate in 1.0 mL of the oral liquid suspension, or
50±5.0 mg topiramate in 2.0 mL of the oral liquid suspension, or
62.5±6.25 mg topiramate in 2.5 mL of the oral liquid suspension, or
75±7.5 mg topiramate in 3.0 mL of the oral liquid suspension, or
100±10.0 mg topiramate in 4.0 mL of the oral liquid suspension, or
125±12.5 mg topiramate in 5.0 mL of the oral liquid suspension, or
150±15.0 mg topiramate in 6.0 mL of the oral liquid suspension, or
175±17.5 mg topiramate in 7.0 mL of the oral liquid suspension, or
200±20.0 mg topiramate in 8.0 mL of the oral liquid suspension, or
250±25.0 mg topiramate in 10.0 mL of the oral liquid suspension is delivered to the subject.